Subcutaneous immunotherapy with house dust mite extract in Indonesian children with allergic rhinitis and asthma: A double-blind randomized controlled trial.
Respiratory medicine · Apr 1, 2026
What's New: House dust mite subcutaneous immunotherapy was associated with reduced symptom scores and key immunological markers in Indonesian children with allergic rhinitis and asthma.
Read more →